moorenard1
Oct 16, 5:45 PM
$CORT
Shorts have knocked Corcept stock from
$126 to
$110 by slamming at open and close every day. They use algorithms to trick automated trading systems and unsophisticated investors. This creates opportunity for the intelligent investor.
There are at least 5 distinct catalysts coming up in next two months, any one of which can spike stock north of
$200 overnight.
(1) Positive cancer results. CORT just had the second best oncology launch in history. More positive data before year end would expand the indication from
$1 to
$5 billion in potential market.
(2) Relacorilant approval in Cushing’s. FDA rejection is expected and baked in to the current share price. A FDA reversal and surprise approval could add
$75 to stock overnight.
(3) Positive MASH results. Game changer. MASH is huge indication, and if CORT has a viable MASH drug they will likely great taken out well north of
$200/sh. This could add
$100 to stock overnight. Big pharma needs this.
0 replies
